This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Revance Therapeutics faces class action
Business class action

Revance Therapeutics faces class action

Analysis based on 6 articles · First reported Jan 08, 2025 · Last updated Jan 24, 2025

Sentiment
-20
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Revance Therapeutics could lead to significant financial and reputational harm for the company, potentially impacting its stock price. Investors who suffered losses during the specified period may be entitled to compensation, creating uncertainty for current shareholders.

Pharmaceuticals Legal Services
Event Summary

Levi & Korsinsky has filed a class action securities lawsuit against Revance Therapeutics, alleging that the company made false and misleading statements to investors between February 29, 2024, and December 6, 2024. The complaint claims that Revance Therapeutics was in material breach of its Distribution Agreement with Teoxane, which granted Revance Therapeutics exclusive rights to distribute Teoxane's dermal fillers. This alleged breach subjected Revance Therapeutics to increased litigation risk, monetary, and reputational harm, and potentially delayed or amended a tender offer. Investors have until March 4, 2025, to request to be appointed as lead plaintiff.

Key Actions
100 Levi & Korsinsky filed class action lawsuit Revance Therapeutics
Entities Involved
stock
Revance Therapeutics
Revance Therapeutics is the defendant in a class action securities lawsuit, facing allegations of making false and misleading statements regarding its distribution agreement with Teoxane.
Importance 100.0 Sentiment -40.0
priv
Teoxane
Revance Therapeutics was allegedly in material breach of its Distribution Agreement with Teoxane, which is a key detail in the class action lawsuit.
Importance 40.0 Sentiment 0.0
priv
Levi & Korsinsky
Importance 0.0 Sentiment 0.0
per
Joseph E. Levi
Importance 0.0 Sentiment 0.0
Relationships
Levi & Korsinsky related ↔ Joseph E. Levi
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.